BamSEC and AlphaSense Join Forces
Learn More

Jazz Pharmaceuticals plc

NASDAQ: JAZZ    
Share price (12/27/24): $124.60    
Market cap (12/27/24): $7.533 billion
Search in Documents
Key Exhibits
External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.1
from 8-K 82 pages License and Collaboration Agreement
12/34/56
EX-2.1
from 8-K 134 pages Transaction Agreement by and Among Jazz Pharmaceuticals Uk Holdings Limited, Jazz Pharmaceuticals Public Limited Company and Gw Pharmaceuticals PLC Dated as of February 3, 2021
12/34/56
EX-2.1
from 8-K 101 pages License Agreement
12/34/56
EX-2.1
from SC TO-C 72 pages Agreement and Plan of Merger Dated as of May 27, 2016, Among Jazz Pharmaceuticals plc, Plex Merger Sub, Inc. and Celator Pharmaceuticals, Inc
12/34/56
EX-2.1
from 8-K 72 pages Agreement and Plan of Merger Dated as of May 27, 2016, Among Jazz Pharmaceuticals plc, Plex Merger Sub, Inc. and Celator Pharmaceuticals, Inc
12/34/56
EX-2.1
from 8-K 59 pages Dated 20 March 2015 JAZZ Pharmaceuticals PLC - And - Essex Bidco Limited Amended and Restated Agreement for the Acquisition of the Topaz Portfolio Business of Jazz Pharmaceuticals plc T0825/00114 Ref: C1/Twb/Jsr Hogan Lovells International Llp Atlantic House, Holborn Viaduct, London Ec1a 2fg Contents
12/34/56
EX-2.1
from 8-K 31 pages Assignment Agreement by and Among JAZZ Pharmaceuticals International II Limited, Sigma-Tau Pharmaceuticals, Inc., Jazz Pharmaceuticals plc and Gentium S.P.A. Dated July 1, 2014
12/34/56
EX-2.1
from 8-K 45 pages Asset Purchase Agreement by and Among JAZZ Pharmaceuticals International III Limited, Aerial Biopharma, LLC and Jazz Pharmaceuticals plc Dated January 13, 2014
12/34/56
EX-2.1
from SC TO-C 78 pages Tender Offer Agreement by and Among Jazz Pharmaceuticals Public Limited Company Jazz Pharmaceuticals Italy S.R.L. and Gentium S.P.A. Dated as of December 19, 2013
12/34/56
EX-2.1
from 8-K/A 78 pages Tender Offer Agreement by and Among Jazz Pharmaceuticals Public Limited Company Jazz Pharmaceuticals Italy S.R.L. and Gentium S.P.A. Dated as of December 19, 2013
12/34/56
EX-2.1
from 8-K 54 pages Continued
12/34/56
EX-2.1B
from 8-K 3 pages Assignment
12/34/56
EX-2.1
from 8-K 96 pages Agreement and Plan of Merger by and Among Jazz Pharmaceuticals Public Limited Company, Jewel Merger Sub Inc., Eusa Pharma Inc., and Essex Woodlands Health Ventures, Inc., Mayflower, L.P., and Bryan Morton as the Stockholders’ Representatives April 26, 2012
12/34/56
EX-2.2
from 8-K12B 6 pages January 17, 2012 To: Jazz Pharmaceuticals PLC (F/K/a Azur Seamus Mulligan Pharma Public Limited Company) Woodlands, Barrymore 45 Fitzwilliam Square Athlone Co., Roscommon Dublin 2, Ireland Ireland Re: Agreement and Plan of Merger and Reorganization, Dated September 19, 2011 JAZZ Pharmaceuticals, Inc. By: /S/ Bruce C. Cozadd Name: Bruce C. Cozadd Title: Chairman & Chief Executive Officer
12/34/56
EX-2.1
from 8-K 86 pages Agreement and Plan of Merger and Reorganization by and Among Azur Pharma Limited, Jaguar Merger Sub Inc., Jazz Pharmaceuticals, Inc. and Seamus Mulligan as Indemnitors’ Representative Dated as of September 19, 2011
12/34/56
EX-2.1
from 425 86 pages Agreement and Plan of Merger and Reorganization by and Among Azur Pharma Limited, Jaguar Merger Sub Inc., Jazz Pharmaceuticals, Inc. and Seamus Mulligan as Indemnitors’ Representative Dated as of September 19, 2011
12/34/56
EX-2.1
from S-1 57 pages Agreement and Plan of Merger Among Jazz Pharmaceuticals, Inc., Twist Merger Sub, Inc. and Orphan Medical, Inc. Dated as of April 18, 2005
12/34/56